[go: up one dir, main page]

AU2002232433A1 - Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 - Google Patents

Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3

Info

Publication number
AU2002232433A1
AU2002232433A1 AU2002232433A AU3243302A AU2002232433A1 AU 2002232433 A1 AU2002232433 A1 AU 2002232433A1 AU 2002232433 A AU2002232433 A AU 2002232433A AU 3243302 A AU3243302 A AU 3243302A AU 2002232433 A1 AU2002232433 A1 AU 2002232433A1
Authority
AU
Australia
Prior art keywords
ethyltransferase
arginine
diagnosis
cancer
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232433A
Inventor
Mark Williamson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2002232433A1 publication Critical patent/AU2002232433A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2002232433A 2000-11-28 2001-11-28 Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 Abandoned AU2002232433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72459900A 2000-11-28 2000-11-28
US09/724,599 2000-11-28
PCT/US2001/044391 WO2002044358A2 (en) 2000-11-28 2001-11-28 Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3

Publications (1)

Publication Number Publication Date
AU2002232433A1 true AU2002232433A1 (en) 2002-06-11

Family

ID=24911066

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232433A Abandoned AU2002232433A1 (en) 2000-11-28 2001-11-28 Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3

Country Status (2)

Country Link
AU (1) AU2002232433A1 (en)
WO (1) WO2002044358A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1402058A4 (en) * 2001-06-05 2006-02-01 Exelixis Inc DGK AS MODULATORS OF THE P53 ACTION MECHANISM AND METHODS OF USE
AU2003238835A1 (en) * 2002-05-30 2003-12-19 Bristol-Myers Squibb Company HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1)
WO2004098634A2 (en) * 2003-04-30 2004-11-18 Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health Protein arginine n-methyltransferase 2 (prmt-2)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060250A (en) * 1998-06-30 2000-05-09 Incyte Pharmaceuticals, Inc. Human transferases
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx

Also Published As

Publication number Publication date
WO2002044358A3 (en) 2002-09-12
WO2002044358A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer